INTRODUCTION
The targeting of proteins to specific membrane domains in polarized mammalian cells is critical for differentiation and the maintenance of normal cellular function [1] . Polypeptides that are sorted to extracytoplasmic locations contain N-terminal signal peptides that have been the focus of numerous studies [2] . In addition, many proteins that are located at the apical surface of polarized cells contain a glycosylphosphatidylinositol (GPI) anchor [3, 4] . In Madin-Darby canine kidney (MDCK) cells the GPI anchor seems to function as an apical sorting signal. Several studies have shown that viral glycoproteins normally located at the basolateral surface of MDCK cells are redirected to the apical membrane when fused to a GPI anchor [5] . Similarly, in polarized intestinal Caco-2 cells, 70 % of a bacterial protein was secreted through the basolateral membrane [6] . However, when the prokaryotic polypeptide was linked to a GPI anchor, it was transported to the apical surface of these cells [7] . The view that the GPI anchor functions as an apical targeting signal is also supported by the observation that several GPI-linked proteins, endogenous to MDCK and Caco-2 cells, are associated exclusively with the apical surface [3] . However, as GPI-anchored proteins can also contain apical sorting signals in their ectodomains [8] [9] [10] [11] , it is possible that the primary role of the GPI anchor in these polypeptides is to facilitate membrane attachment.
Although GPI-anchored proteins generally exhibit apical targeting, the GPI-anchored protein p137 displays bidirectional transcytosis in Caco-2 cells, although it is not clear whether the GPI anchor itself mediates this process [12] . In contrast with MDCK and Caco-2 cells, endogenous GPI-anchored proteins, and a chimaeric polypeptide in which the GPI anchor was fused to herpes simplex gD-1, were localized at the basolateral surface of Fischer rat thyroid epithelial cells [13] . Polarized primary thyrocytes, however, contain GPI-linked polypeptides on their apical membranes [14] .
From the foregoing discussion it is apparent that the membrane location of GPI-anchored proteins varies between different mammalian cell lines, and that protein sorting data in itro do Abbreviations used : EGE, endoglucanase E ; EGEh, catalytic domain of endoglucanase E linked to a eukaryotic signal peptide ; EGEd, catalytic domain of EGE fused to a eukaryotic signal peptide and a GPI anchor attachment sequence ; FITC, fluorescein isothiocyanate ; GPI, glycosylphosphatidylinositol ; MCR, multiple cloning regions ; MDCK, Madin-Darby canine kidney ; TEM, transmission electron microscopy.
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polarized epithelial cells of transgenic mice. The bacterial enzyme, when fused to a eukaryotic signal peptide, was secreted through the basolateral membrane of small-intestinal enterocytes ; however, when the enzyme was linked to the GPI anchor sequence the polypeptide was redirected to the apical surface of the epithelial cells. These data provide the first direct evidence that the GPI anchor functions as an apical membrane protein sorting signal in polarized epithelial cells in i o.
not always reflect the trafficking of proteins in i o. To evaluate whether the GPI anchor functions as an apical sorting signal in polarized intestinal cells in i o, we have expressed two forms of a bacterial protein in the small-intestinal enterocytes of transgenic mice. The protein, when fused to a eukaryotic signal peptide, was secreted primarily through the basolateral membrane into the bloodstream. In contrast, the prokaryotic polypeptide, when linked to a mammalian signal peptide and a GPI anchor sequence, was located on the apical surface of the intestinal enterocytes and in the small-intestinal lumen. These results provide direct evidence that the GPI anchor functions as an apical membrane protein sorting signal in polarized cells in i o.
MATERIALS AND METHODS

Plasmid construction
The bacterial genes used in this study are derivatives of celE, a gene that encodes endoglucanase E (EGE) from Clostridium thermocellum [15] . The two derivatives of celE that were used to generate transgenic mice were constructed as follows. The promoter of the gene encoding the rat intestinal fatty acid binding protein, extending from nucleotides k1178 to j8 [16] , derived from pHGG1, was inserted into pMTL20p [17] on a 1.2 kb KpnI\BamHI restriction fragment to generate pSA3. The DNA sequences encoding the catalytic domain of EGE fused to the human growth hormone signal peptide [18] and Thy-1.2 GPI anchor (EGEd ; [19] ), and the catalytic domain of EGE fused to the human growth hormone signal peptide (EGEh), were excised from pSRαEGETHY1 [7] and pCELEE [18] , respectively, on 3.3 kb and 3.1 kb BamHI\StuI restriction fragments and cloned into BamHI\StuI-digested pSA3 to create pSA2 and pSA1, respectively ( Figure 1 ).
Generation of transgenic mice
The celEh-containing DNA inserts in pSA1 and pSA2 were excised on 4.2 and 4.5 kb XhoI restriction fragments respectively.
Figure 1 Physical map of recombinant plasmids encoding EGEh and EGEd
The The DNA fragments were purified by agarose gel electrophoresis and NACS column chromatography. The DNA was diluted in 10 mM Tris\HCl buffer, pH 7.4, containing 0.1 mM EDTA, to a concentration of 4 ng\ml and injected into the pronuclei of freshly fertilized eggs derived from the progeny of a mating between [C57BL6iCBA] F " mice. Approximately 700 eggs were injected with each construct. Embryos were cultured overnight in M16 medium, and viable embryos were transferred to the infundibulum of the fallopian tubes of pseudopregnant mice.
Approximately 30 eggs were implanted per mouse. Live-born mice, at 3 weeks of age, were anaesthetized with halothane, before removing a tail biopsy for screening for the presence of the transgenes by probing Southern blots of SstI-digested tail DNA with $#P-labelled celEh. Founder animals were mated with [C57BL6iCBA] F1 mice to establish pedigrees hemizygous for the transgenes.
Quantification of EGEh
Transgenic mice were anaesthetized with halothane, bled and then killed by cervical dislocation. Intestines were divided into five segments defined as the duodenum, jejunum, ileum, caecum and colon. The tissues were resuspended in 1 ml of 50 mM Tris\HCl buffer, pH 7.5, containing 250 mM sucrose (buffer A), and treated in one of two ways. (1) The tissues were washed in buffer A, homogenized and the cellular debris was pelleted by centrifugation at 13 000 g for 20 min at 4 mC ; the cleared homogenate was assayed for EGEh antigen. (2) The tissue segments were cut open longitudinally and vortex-mixed in buffer A. The intestinal tissue was removed and the luminal contents were centrifuged for 10 min at 4 mC ; the supernatant was assayed for EGEh antigen. To analyse EGEh in the systemic circulation, blood was allowed to clot and serum was separated by centrifugation. EGEh in the various samples was quantified by competitive inhibition ELISA as follows : micro-ELISA plates were coated for 15 h at 4 mC with EGEh at 0.1 µg\ml in PBS. The plates were then washed four times with PBS containing 0.1 % Tween-20 and 0.1 % BSA. Soluble antigen standards (1-500 ng\ml) and appropriate samples (50 µl) were added to individual wells followed by 25 µl of primary antibody diluted 1 : 1000 in PBS containing 0.1 % Tween-20 and 0.2 % BSA (PTB buffer). After incubation at room temperature for 2 h, the plates were washed four times in PTB buffer. Goat anti-rabbit IgG coupled to hydrogen peroxidase, diluted 1 : 1000 in PTB buffer, was added to each well, and after incubation for 1 h at 22 mC, excess secondary antibody was removed by washing the plates four times with PTB buffer. Bound antibody conjugate was detected by the addition of 100 mM sodium acetate buffer, pH 6.0, containing 0.1 mg\ml 3,3h,5,5h-tetramethyl benzidine and 0.06 mg\ml hydrogen peroxide. The enzyme reaction was terminated after 15 min by the addition of 20 % (v\v) sulphuric acid, and the A %&! was measured with a Dynatech MR5000 microplate reader. The concentration of EGEh in the samples was determined from a standard curve of log (EGEh concentration) against A %&! .
Transmission electron microscopy (TEM)
Adult mice were killed by cervical dislocation, the abdomen was incised and 1 cm lengths of jejunum were removed. The excised tissues were cut open along their mesenteric edges and pinned flat, mucosal surface uppermost, on cork boards. The tissues were washed thoroughly with PBS and immersed in 100 mM sodium phosphate buffer, pH 7.3, containing 2 % (w\v) glutaraldehyde, for 5 h at 4 mC. After washing with PBS, the cells were permeabilized with 0.1 % Triton X-100 at room temperature for 30 min. Endogenous peroxidase activity was blocked by immersing the tissues in 0.3 % hydrogen peroxide solution in 100 % (v\v) methanol for 15 min at room temperature. After rinsing with PBS, the tissues were incubated with a 1 : 100 dilution (diluted in PBS) of rabbit anti-EGEh antiserum at 4 mC for 16 h. After washing with PBS, the tissues were incubated with goat serum, diluted 1 : 3 (v\v) in PBS, for 30 min at room temperature, and then with a 1 : 400 dilution of goat anti-rabbit IgG antibodies conjugated to hydrogen peroxidase for 1 h at room temperature. The tissues were then washed in PBS and bound second antibody conjugate was detected by immersing the tissue for 15 min in 2.8 mM 3,3h-diaminobenzidine tetrahydrochloride containing 0.02 % hydrogen peroxide. Tissues were then processed for TEM by immersion in an aqueous solution of 1 % OsO % for 1 h at 4 mC, followed by washing in 100 mM sodium phosphate buffer, pH 7.3. Samples were dehydrated successively in 25, 50, 75 and 100 % (v\v) acetone, then immersed successively for 1 h in 1 : 4, 1 : 3 and 1 : 2 acetone\epoxy resin and then embedded in epoxy resin at 60 mC for 24 h. Sections (70 nm thick) were cut, transferred to a 100-mesh Formvar-coated copper grid, stained with 4 % (w\v) uranyl acetate for 1 h at 20 mC and saturated lead citrate for 30 min at 20 mC and examined with a Phillips CM100 electron microscope.
Confocal microscopy
Samples were removed and immediately frozen in OCT embedding compound on to cork squares in liquid-nitrogencooled isopentane. Sections, 8 µm thick, of frozen tissue were dried on poly--lysine-coated slides and fixed in methanol at k20 mC for 20 min. Sections were then incubated with anti-EGEh antiserum, diluted 1 : 100 in PBS, for 13 h at 4 mC. Unbound antibody was removed by washing the tissues in PBS which were then incubated with goat serum, diluted 1 : 3 in PBS, for 30 min at room temperature. EGEh-antibody complexes were detected by incubating the tissues with fluorescein isothiocyanate (FITC)-labelled goat anti-rabbit IgG antibodies (diluted 1 : 80 in PBS) for 1 h at 22 mC. Unbound fluorescent antibody was removed by washing with PBS. To locate alkaline phosphatase, antibody-stained sections were washed with water and PBS, and were then immersed in 200 mM Tris\HCl buffer, pH 8.5, containing 0.52 mM naphthol AS-MX phosphate, 1 mg\ml Fast Red TR salt and 1 mM levamisole for 5 min at room temperature. The tissues were washed in PBS and water, dehydrated in ethanol and mounted in Vectashield mounting medium. Fluorescent images were collected with a Bio-Rad MRC600 confocal laser scanning image system, with an argon ion laser attached to a Nikon Diaphot microscope.
RESULTS
To determine the secretory route of a prokaryotic endoglucanase in polarized mammalian epithelial cells in i o, a derivative of celE [15] that encodes EGE from C. thermocellum was expressed in transgenic mice. A derivative of the gene (celEh) encoding EGEh was fused to a small-intestinal-specific promoter and a mammalian polyadenylation signal (Figure 1 ), and the DNA was used to generate six transgenic mouse lines. As endoglucanase activity is absent from mammalian cells, EGEh is
Figure 2 Small-intestinal expression of EGEh
Tissues from the duodenum, jejunum, ileum, caecum and colon of four transgenic lines that contain the insert from pSA1 (upper panel) and six transgenic lines that contain the insert from pSA2 (lower panel) were assayed for EGEh antigen and protein. Bars with the same pattern in either the upper or lower panels denote data from the same transgenic line. The standard errors for each determination are shown.
Figure 3 EGEh in the intestinal lumen and blood of transgenic mice
The upper panel shows the quantity of EGEh in the blood and small-intestinal lumen of four transgenic lines that express EGEh (contains the insert from pSA1). The lower panel displays the level of EGEd in the blood and small-intestinal lumen of six transgenic lines that synthesize EGEd (contain the insert from pSA2). Bars with the same pattern in either the upper or lower panels denote data from the same transgenic line. The standard errors for each determination are shown. a sensitive reporter for studying protein secretory pathways. Analysis of tissues from the transgenic mice revealed that in four of the lines EGEh was expressed primarily in small-intestinal enterocytes located in the jejunum and ileum (Figure 2 , upper panel). No endoglucanase activity was detected in the stomach, liver, lung, heart or spleen (results not shown), consistent with the reported tissue specificity of the promoter [16] . The other two transgenic lines did not synthesize EGEh. To determine whether EGEh was secreted from the small-intestinal epithelia and, if so, whether the enzyme was exported through the basolateral and\or apical membrane, the small-intestinal lumen and blood were analysed for EGEh antigen. The data, presented in Figure 3 (upper panel), showed that endoglucanase in the blood and small-intestinal lumen was in the ratio 8 : 1, indicating that the enzyme was secreted primarily through the basolateral membrane.
To evaluate whether the GPI anchor can act as a dominant apical sorting signal in small-intestinal enterocytes in i o, transgenic mice were generated containing a derivative of celE (celEd) transcribed from a small-intestine-specific promoter that encodes EGEh fused to a GPI anchor attachment sequence (EGEd ; Figure 1) . Analysis of the 15 transgenic lines generated revealed six lines that expressed EGEd in smallintestinal tissue (Figure 2 ; lower panel) , but not in the other organs analysed (lung, heart, liver, spleen and stomach ; results not shown). As with the EGEh transgenic lines, EGEd was expressed predominantly in the jejunum and ileum ( Figure  2) . TEM of small-intestinal enterocytes derived from transgenic lines expressing EGEd, and labelled with anti-EGEh antibodies, revealed that a significant proportion of the endoglucanase was located on the apical microvilli (Figure 4 , upper right panel), with no evidence for EGEd at the basolateral surface of the intestinal cells. The enzyme was detected both in small intracellular vesicles and in large multivesicular bodies (Figure 4 , upper right panel). In contrast, TEM of small-intestinal enterocytes synthesizing EGEh indicated that the endoglucanase was not targeted to the apical surface but was localized in small vesicles that accumulated towards the basolateral surface of the enterocytes (Figure 4, upper left panel) . Examination of duallabelled EGEd-expressing intestinal cells by confocal microscopy revealed that the endoglucanase co-localized with alkaline phosphatase to the apical surface. The EGEd was exterior to the alkaline phosphatase staining (Figure 4 , lower right panel), consistent with the strong EGEd staining at the microvillus tips observed by TEM (Figure 4, upper right panel) . In addition, significant EGEd staining was also observed in the small-intestinal lumen (Figure 4, lower right panel) . In contrast, confocal microscopy of cells that synthesized non-GPI-anchored EGEh showed that the enzyme was cytoplasmic, with minimal colocalization with alkaline phosphatase at the apical surface (Figure 4 , lower left panel), consistent with the weak EGEh staining of the brush-border membrane observed by TEM ( Figure  4, upper left panel) . The luminal location of a proportion of EGEd was consistent with the structure of the hybrid protein ; the GPI anchor was fused to the catalytic domain of EGEh via a proteinase-sensitive hydroxyamino acid-rich linker sequence [7, 15] . Indeed, treatment of Caco-2 cells expressing EGEd with trypsin rapidly released the polypeptide from the apical membrane [7] . To confirm the secretory route of the GPI-anchored endoglucanase, EGEd antigen was quantified in the blood and small-intestinal lumen of these animals. The data, presented in Figure 3 , showed that the ratio of blood\small-intestinal lumen EGEd was 0.17 : 1. This is the reverse of the ratio observed for the non-GPI-anchored endoglucanase. This value is an underestimate of the EGEd that has been sorted to the apical surface of the epithelial cells, as it does not take account of the enzyme that is still attached to the apical membrane. Western analysis of luminal proteins showed that the secreted form of EGEd had a molecular mass of 36 kDa, which was identical with non-glycosylated EGEh treated with small-intestinal proteinases ( Figure 5 ). In contrast, intracellular EGEd had a molecular mass of 50 kDa ( Figure 5 ), which is similar to the size of glycosylated EGEh expressed by several mammalian cell lines [6, 18, 20] . It is therefore likely that α-glycosidases in the small-intestinal lumen deglycosylate the secreted enzyme. Glycosylated and deglycosylated forms of the enzyme have equivalent endoglucanase activities and kinetic characteristics [20] .
DISCUSSION
The primary objective of this study was to evaluate the influence of the Thy-1 GPI anchor on the secretory route of EGE. When EGEh was expressed in small-intestinal enterocytes of transgenic mice, more than 80 % of the extracellular form of the enzyme was located in the bloodstream, suggesting that the endoglucanase was secreted through the basolateral membrane of the intestinal cells. It could be argued that any EGEh secreted into the gastrointestinal tract would be rapidly degraded by pancreatic and other luminal proteinases, and thus the relative absence of the enzyme in the small-intestinal lumen might not necessarily reflect a non-apical secretory route for the endoglucanase. However, EGEh is resistant to intestinal proteinases and remains fully active when secreted into the small-intestinal lumen [21] . Thus the results shown in Figure 3 indicate that most EGEh in small-intestinal enterocytes is exported through the basolateral membrane. As there is no evidence in this prokaryotic enzyme for the evolution of sorting signals other than the N-terminal signal peptide [6] , the secretory route of EGEh defines the default pathway of protein secretion from these cells in i o. The results described above are comparable with previous studies in itro that have defined the default pathway in Caco-2 cells, a culture model for differentiated small-intestinal enterocytes, which is predominantly (70 %) through the basolateral membrane [10, 22, 23] .
Recent results have suggested that the N-glycosylation of rat growth hormone targets the protein to the apical surface of MDCK cells [24] . EGEh is N-glycosylated in Caco-2 and MDCK cells in itro [6, 7] , as well as in intestinal enterocytes in i o. However, this glycosylation does not result in the apical targeting of this bacterial protein, suggesting that a role for N-glycans in apical protein sorting is not generic.
Results from confocal microscopy and TEM of intestinal tissue indicated that EGEd was associated with the apical membrane of small-intestinal enterocytes in i o. In contrast, in itro studies revealed a significant proportion of GPI-anchored EGEd at the basolateral surface of enterocyte-like Caco-2 cells, with subsequent transcytosis to the apical surface [7] . Results presented in this report provide no evidence for basolateral delivery of the GPI-anchored endoglucanase in i o. The observation that EGEh was located only in the cytoplasm of intestinal cells confirmed that the GPI anchor targeted EGEd to the apical membrane of small-intestinal enterocytes in i o. TEM of intestinal enterocytes revealed that the bacterial protein was located in both small and large vesicles. GPIanchored proteins have similarly been shown to accumulate in multivesicular bodies in a variety of non-polarized cells in itro, including those of intestinal epithelial origin [25, 26] . Field et al. [25] have shown that in CHO and COS cells, failure to cleave the C-terminal protein sequence that directs the addition of a GPI anchor prevents the proteins from entering the cis-Golgi complex, and they are then degraded in large non-lysosomal vesicles. It is therefore possible that in a proportion of EGEd molecules the Cterminal region, which signals the addition of the GPI anchor, is not cleaved and the endoglucanase, instead of entering the cisGolgi complex, is degraded in large multivesicular bodies.
In view of the dominant role that the GPI anchor plays in directing EGEd to the apical membrane, it is probable that in small-intestinal enterocytes this sequence also determines the cellular location of several endogenous GPI-anchored proteins that associate with the apical membrane. However, in contrast with EGEd, where a small proportion of the enzyme (less than 15 %) is secreted through the basolateral membrane, endogenous GPI-anchored proteins are present at very low levels in the blood. This might be explained by the identification of apical sorting signals in the ectodomain of some GPI-anchored proteins, such as decay accelerating factor, Thy-1.2 and placental alkaline phosphatase [8] [9] [10] [11] , although the generality of this observation has yet to be demonstrated for GPI-anchored polypeptides derived from small-intestinal enterocytes.
To conclude, this report directly demonstrates that the GPI anchor functions as a dominant apical sorting signal in smallintestinal enterocytes in i o and thus is likely to play a major role in targeting endogenous proteins to the apical surface of these cells. In addition, in view of the potential applications of generating transgenic mammals with the capacity to secrete exogenous proteins into the gastrointestinal tract [21] , we have demonstrated the utility of the GPI anchor for directing heterologous polypeptides into the small-intestinal lumen.
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